Landauer, Inc. (NYSE:LDR) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Wednesday.
According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “
LDR has been the topic of a number of other research reports. Hilliard Lyons upgraded shares of Landauer from an “underperform” rating to a “neutral” rating in a research report on Wednesday, September 6th. BidaskClub upgraded shares of Landauer from a “strong sell” rating to a “sell” rating in a research report on Wednesday, August 9th.
Shares of Landauer (NYSE LDR) opened at 67.25 on Wednesday. The firm’s 50-day moving average is $65.87 and its 200 day moving average is $56.30. Landauer has a 12 month low of $41.00 and a 12 month high of $68.50. The stock has a market cap of $648.16 million, a PE ratio of 34.83 and a beta of 1.29.
Landauer (NYSE:LDR) last posted its quarterly earnings data on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.49 by $0.18. Landauer had a net margin of 12.09% and a return on equity of 80.03%. The business had revenue of $39.89 million for the quarter. On average, equities analysts predict that Landauer will post $1.95 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This piece was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2017/10/11/landauer-inc-ldr-rating-increased-to-hold-at-zacks-investment-research.html.
Several institutional investors and hedge funds have recently modified their holdings of the company. Eqis Capital Management Inc. purchased a new stake in shares of Landauer during the third quarter valued at $376,000. U S Global Investors Inc. boosted its stake in shares of Landauer by 43.1% during the second quarter. U S Global Investors Inc. now owns 22,746 shares of the scientific and technical instruments company’s stock valued at $1,190,000 after purchasing an additional 6,846 shares during the period. State Street Corp boosted its stake in shares of Landauer by 4.1% during the second quarter. State Street Corp now owns 240,914 shares of the scientific and technical instruments company’s stock valued at $12,603,000 after purchasing an additional 9,567 shares during the period. Janus Henderson Group PLC purchased a new stake in shares of Landauer during the second quarter valued at $298,000. Finally, Punch & Associates Investment Management Inc. boosted its stake in shares of Landauer by 1.9% during the second quarter. Punch & Associates Investment Management Inc. now owns 272,761 shares of the scientific and technical instruments company’s stock valued at $14,265,000 after purchasing an additional 5,120 shares during the period. 79.57% of the stock is owned by hedge funds and other institutional investors.
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.